Supplementary Materials
fig. S1. Gene expression during hPSC differentiation to BMECs. Quantitative RT-PCR was used to quantify the expression of the indicated genes during hPSC differentiation to BMECs using the process illustrated in Fig. 1A . Genes analyzed include the pluripotency transcription factor NANOG, primitive streak markers T and MIXL1, intermediate mesoderm marker PAX2, endothelial cell progenitor marker CD34, endothelial adhesion molecule CDH5, tight junction genes TJP1, CLDN5 and OCLN, and efflux transporter ABCB1. GAPDH was used as an endogenous housekeeping gene control. Data are represented as mean ± SEM of three independent replicates. including IM90-4, H9, 19-9-11 hPSCs, were seeded at the optimum density (35k cells/cm 2 ) and differentiated to BMECs as illustrated in Fig. 1A . TEER was measured two days after replating on Transwell membranes at 10 6 cells/cm 2 . Average TEER values are presented as mean±S.D. calculated from a set of independent replicates, where each replicate is defined as a distinct BMEC differentiation experiment. Coefficient of variation (CV%) was calculated by S.D./mean x 100. (B) H9 hPSCs and 19-9-11 iPSCs were seeded at the indicated densities (from 8.8k/cm 2 to 140k/cm 2 ) and differentiated to BMECs as illustrated in Fig. 1A . TEER was measured two days after replating on Transwell membranes at 10 6 cells/cm 2 . Data were collected from three independent replicates for each group and presented as mean ± SEM. Primer length  Product length  GAPDH-3  207  Forward  CTGATTTGGTCGTATTGGGC  20  Reverse  TGGAAGATGGTGATGGGATT  20  SLC2A1  140  Forward  AACTCTTCAGCCAGGGTCCAC  21  Reverse  CACAGTGAAGATGATGAAGAC  21  ABCB1  207  Forward  CTCATCGTTTGTCTACAGTTCG  22  Reverse  AAGACATTTCCAAGGCATCA  20  PECAM1  117  Forward  GAGTATTACTGCACAGCCTTCA  22  Reverse  AACCACTGCAATAAGTCCTTTC  22  OCLN  132  Forward  GACTTCAGGCAGCCTCGTTAC  21  Reverse  GCCAGTTGTGTAGTCTGTCTCA  22  CLDN5  238  Forward  GTTCGCCAACATTGTCGTCC  20  Reverse  GTAGTTCTTCTTGTCGTAGTCGC  23  TJP1  128  Forward  ACCAGTAAGTCGTCCTGATCC  21  Reverse  TCGGCCAAATCTTCTCACTCC  21  CDH5  179  Forward  AAGCGTGAGTCGCAAGAATG  20  Reverse  TCTCCAGGTTTTCGCCAGTG  20  KDR  124  Forward  GTGATCGGAAATGACACTGGAG  22  Reverse  CATGTTGGTCACTAACAGAAGCA  23  CD34  185  Forward  CTACAACACCTAGTACCCTTGGA  23  Reverse  GGTGAACACTGTGCTGATTACA  22  POU5F1  120  Forward  GTGGAGGAAGCTGACAACAA  20  Reverse  ATTCTCCAGGTTGCCTCTCA  20  NANOG  116  Forward  TTTGTGGGCCTGAAGAAAACT  21  Reverse  AGGGCTGTCCTGAATAAGCAG  21  T  143  Forward  GGGAGCGAGGAGGAAGGGAA  20  Reverse  TGGTGACGGTGCTGAAGTGC  20  MIXL1  130  Forward  GGCGTCAGAGTGGGAAATCC  20  Reverse  GGCAGGCAGTTCACATCTACC  21  PAX2  92  Forward  TCAAGTCGAGTCTATCTGCATCC  23  Reverse  CATGTCACGACCAGTCACAAC  21 
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